Article
Unscheduled in-office investigations can be a fact of life, but what about when you aren't in the office? Discover what your practice's action plan needs to include.
U.S. dementia costs to reach $781 billion in 2025 — who’s really paying for it
Ep. 61: Prior authorization with Heather Bassett, MD
Orchestra BioMed receives Breakthrough Device Designation for its hypertension therapy
Ep. 60: Strategic planning with Stephen A. Dickens of SVMIC
FDA approves Medtronic’s Simplera Sync Sensor for use with MiniMed 780G Insulin System
Data-driven scheduling cuts diabetes risks by 19% for vulnerable patients